betaxolol has been researched along with metipranolol in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (36.36) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
de Dieuleveult, C; Pinaud, M; Queinnec, MC; Souron, R | 1 |
James, IM | 1 |
De Heer, LJ; De Keizer, RJ; Maas, S; Ros, FE | 1 |
Johns, MD; Ponte, CD | 1 |
Zimmerman, TJ | 1 |
Frishman, WH; Fuksbrumer, MS; Tannenbaum, M | 1 |
Kijlstra, A; Mulder, M; van Beek, LM; van Haeringen, NJ | 1 |
Allmeier, H; Chidlow, G; Melena, J; Osborne, NN; Schmidt, KG; Wood, JP | 1 |
4 review(s) available for betaxolol and metipranolol
Article | Year |
---|---|
Pharmacologic effects of beta-blocking agents used in the management of glaucoma.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Heart Rate; Humans; Intraocular Pressure; Levobunolol; Metipranolol; Propanolamines; Solubility; Timolol | 1989 |
Acute pulmonary edema associated with ocular metipranolol use.
Topics: Aged; Betaxolol; Clinical Trials as Topic; Female; Glaucoma; Humans; Metipranolol; Ophthalmic Solutions; Pulmonary Edema | 1995 |
Topical ophthalmic beta blockers: a comparative review.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Carteolol; Drug Tolerance; Glaucoma; Humans; Intraocular Pressure; Levobunolol; Metipranolol; Ophthalmic Solutions; Timolol | 1993 |
Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Humans; Levobunolol; Metipranolol; Ocular Hypertension; Timolol | 1994 |
2 trial(s) available for betaxolol and metipranolol
Article | Year |
---|---|
[Comparison in healthy volunteers of the systemic beta adrenergic receptor blockade by beta blockader eye drops].
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, General; Betaxolol; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Isoproterenol; Male; Metipranolol; Ophthalmic Solutions; Placebos; Propanolamines | 1989 |
Efficacy and safety of the combination therapy Pilogel/beta-blocker: interim results.
Topics: Adrenergic beta-Antagonists; Aged; Betaxolol; Circadian Rhythm; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gels; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Metipranolol; Middle Aged; Multicenter Studies as Topic; Ocular Hypertension; Pilocarpine; Pupil; Refraction, Ocular; Timolol | 1989 |
5 other study(ies) available for betaxolol and metipranolol
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
New topical beta-blockers for glaucoma.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Humans; Metipranolol; Propanolamines | 1987 |
Topical ophthalmic beta blockers may cause release of histamine through cytotoxic effects on inflammatory cells.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Basophils; Betaxolol; Carteolol; Cells, Cultured; Dose-Response Relationship, Drug; Histamine Release; Humans; L-Lactate Dehydrogenase; Leukocytes; Metipranolol; Timolol | 2000 |
The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol.
Topics: Adrenergic beta-Antagonists; Animals; Betaxolol; Calcium; Cell Hypoxia; Cell Survival; Cells, Cultured; Electroretinography; Metipranolol; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion Injury; Retina; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium; Thy-1 Antigens; Timolol | 2003 |